Signals
Schizophrenia Gets a Five-Day Brain-Stimulation Signal
A small sham-controlled trial found substantial short-term symptom improvement after fronto-temporal tDCS in treatment-resistant schizophrenia. The signal is striking. The evidence is still much too small to call it a treatment answer.
Myasthenia Care Cannot Wait for Crisis
Dermatophilus Changed Pattern.
AI can find hidden heart disease in routine ECGs. The policy challenge is deciding who gets fast-tracked
Do patients need maximum-dose tirzepatide forever? New data suggest a middle ground
C. Diff Can Hide in Plain Sight.
Sprint interval training triggered a bigger molecular response than 90 minutes of cycling. Bigger is not yet better
Nearly two-thirds showed no measurable fitness gain after short cardiac rehab. AI may identify who needs a different plan
One in four Korean adults met MASLD criteria. Four everyday habits were linked to 29% lower odds
Hantavirus Tested Europe’s Borders
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.